MUC5AC and colorectal cancer: The 11 studies analyzing the prognostic relevance of MUC5AC expression in colorectal cancer in cohorts of 35–649 patients have found divergent results [11, 12, 17, 18, 20, 21, 23, 25, 31, 34, 35].